DLEC1 Antikörper (AA 124-1622) (FITC)
Kurzübersicht für DLEC1 Antikörper (AA 124-1622) (FITC) (ABIN7984769)
Target
Alle DLEC1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 124-1622
-
Verwendungszweck
- Anti-DLEC1 Antibody FITC Conjugated
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human DLEC1 recombinant protein (Position: E124-Q1622).
-
Isotyp
- IgG
-
-
anti-Deleted in Lung and Esophageal Cancer 1 (DLEC1) (N-Term) antibody
DLEC1 Reaktivität: Human ELISA, WB, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Deleted in Lung and Esophageal Cancer 1 (DLEC1) (AA 879-908) antibodyDLEC1 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB19455 unconjugated
-
-
Applikationshinweise
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Haltbarkeit
- 12 months
-
-
- DLEC1 (Deleted in Lung and Esophageal Cancer 1 (DLEC1))
-
Andere Bezeichnung
- DLEC1
-
Hintergrund
-
Background: The cytogenetic location of this gene is 3p21.3, and it is located in a region that is commonly deleted in a variety of malignancies. Down-regulation of this gene has been observed in several human cancers including lung, esophageal, renal tumors, and head and neck squamous cell carcinoma. In some cases, reduced expression of this gene in tumor cells is a result of aberrant promoter methylation. Several alternatively spliced transcripts have been observed that contain disrupted coding regions and likely encode nonfunctional proteins.
Gene Full Name: DLEC1 cilia and flagella associated protein
-
Gen-ID
- 9940
-
UniProt
- Q9Y238
Target
-
